Branched-chain
fatty acids (BCFA) are encountered in Gram-positive
bacteria, but less so in other organisms. The bacterial BCFA in membranes
are typically saturated, with both odd- and even-numbered carbon chain
lengths, and with methyl branches at either the ω-1 (iso) or ω-2 (anteiso) positions.
The acylation with BCFA also contributes to the structural diversity
of microbial natural products and potentially modulates biological
activity. For the tunicamycin (TUN) family of natural products, the
toxicity toward eukaryotes is highly dependent upon N-acylation with trans-2,3-unsaturated BCFA. The
loss of the 2,3-unsaturation gives modified TUN with reduced eukaryotic
toxicity but crucially with retention of the synergistic enhancement
of the β-lactam group of antibiotics. Here, we infer from genomics,
mass spectrometry, and deuterium labeling that the trans-2,3-unsaturated TUN variants and the saturated cellular lipids found
in TUN-producing Streptomyces are derived from the
same pool of BCFA metabolites. Moreover, non-natural primers of BCFA
metabolism are selectively incorporated into the cellular lipids of
TUN-producing Streptomyces and concomitantly produce
structurally novel neo-branched TUN N-acyl variants.